Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 07 Jul 2016  |  Global  |  Technology Research

    Regenerative Medicine - The Future of Therapy (TechVision)

    After many years of basic research, regenerative medicine represents a remarkable foremost innovation in medical care. Comprising principles of stem cell technology and tissue engineering, also combining advanced biomaterials with small molecules and biologics, to replace or regenerate human tissues and organs and restore their functions, regenerat...

    $4,950.00

    Special Price $3,712.50 save 25 %

  2. 30 Mar 2016  |  Global  |  Technology Research

    Next Generation Diabetes Therapy and Drug Delivery Technologies

    Global Diabetes Epidemic Adds Urgency to R&D Initiatives, Inhalable and Transdermal Delivery on Upward Trajectory

    Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...

    $4,950.00

    Special Price $3,712.50 save 25 %

  3. 29 Dec 2015  |  Global  |  Technology Research

    Collaboration between Medical Devices, Pharmaceuticals, and Biotechnology

    Strategic Partnerships that are Transforming the Healthcare Industry

    In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships. Market segments such as personalized med...

    $4,950.00

    Special Price $3,712.50 save 25 %

  4. 29 Sep 2015  |  Global  |  Technology Research

    Advances in monoclonal antibody therapeutics

    Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets,...

    $4,950.00

    Special Price $3,712.50 save 25 %

  5. 29 Jun 2015  |  Global  |  Technology Research

    Trends in mammalian cell cultures

    Technology Market Penetration and Roadmapping

    With the growing need for better therapeutics, and the current patent cliff that is underway, therapies such as monoclonal antibodies, recombinant protein therapeutics and even vaccines for a whole host of indications are in high demand. Conventionally expression systems were utilized to aid in the development and production of these therapeutics...

    $4,950.00

    Special Price $3,712.50 save 25 %

  6. 03 Sep 2013  |  Global  |  Technology Research

    Innovations in Allergy Treatment and Monitoring (Technical Insights)

    Therapy and Monitoring Advances Help Achieve Long-term Relief from Allergy

    The global human plasma-derived therapeutics market is expected to experience a surge in demand due to an increase in the awareness of diseases and therapeutic options. The plasma-derived therapeutics market is segmented into albumin, immunoglobulins, coagulation factors, and other haemotologicals. The segments are discussed with supporting informa...

    $4,950.00

    Special Price $3,712.50 save 25 %

  7. 19 Jan 2012  |  Global  |  Technology Research

    Advances in Pharmacovigilance Techniques--Technology Benchmarking and Stakeholder Analysis (Technical Insights)

    A Drug Safety Toolkit Moving toward Improved Drug Safety Systems

    Pharmacovigilance activities revolve around ensuring drug safety and preventing adverse drug reactions. While post marketing studies form the core of pharmacovigilance, inclusion of safety measures during clinical development and carrying out additional post marketing active surveillance is being utilized by a number of pharma companies.  Risks due...

    $4,950.00

    Special Price $3,712.50 save 25 %